Table 1.

Single-rate meta-analysis of adverse events after linezolid therapy in 758 children from nine studies

Adverse events	Number of events	Proportion, %	95% CI
Total adverse events	205	8.91	1.64%–36.52%
Diarrhea	39	2.24	0.43%–0.81%
Vomiting	16	2.05	0.99%–4.17%
Rash	13	1.72	1.00%–2.93%
Nausea	13	0.96	0.23%–3.91%
Thrombocytopenia	12	0.68	0.05%–8.47%
Hepatic injury	41	0.51	0.03%–9.23%
Loose stools	8	0.30	0.01%–5.74%
Abdominal pain	13	0.23	0.01%–4.75%
Neutropenia	19	0.21	0.00%–9.28%
Anemia	5	0.16	0.00%–5.78%

CI confidence interval